Raymond D. Meng
Raymond D. Meng publishes mostly in Oncology, Molecular Biology and Immunology, on topics such as Cancer Immunotherapy and Biomarkers, Cancer-related Molecular Pathways and PI3K/AKT/mTOR signaling in cancer.
- World rank
- #1,011,169 of 7,710,434 ranked researchers
- Rank in United States
- #329,761 of 1,627,098
- Works
- 50
- Citations
- 2.2k
- Citations per work
- 43.2
What does Raymond D. Meng research?
Raymond D. Meng's work is mostly in Medicine (45%), Biochemistry, Genetics and Molecular Biology (26%), Immunology and Microbiology (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2345.2%
- Medicine2345.2%
- Life Sciences1836.6%
- Everything else918.2%
- 1Oncology33% of their works
- 2Molecular Biology21% of their works
- 3Immunology11% of their works
- 4Pulmonary and Respiratory Medicine10% of their works
- 5Biotechnology5% of their works
- 6Pathology and Forensic Medicine3% of their works
Research topics
Which keywords describe Raymond D. Meng's research?
The keywords of their largest research topics: Immune Checkpoint Blockade, PD-1 and PD-L1, Cell Cycle, Immunotherapy, p53, Tumor Regression, Gene Therapy and mTOR.
- AAV
- CAR T Cells
- Targeted Therapy
- NK Cell Recognition
- Bacterial Therapy
- Signaling
- p53
- Immunotherapy
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Cell Cycle
- Tumor Regression
- Gene Therapy
- mTOR
- EGFR Mutations
- Natural Killer Cells
- Tumor Targeting
- Chimeric Antigen Receptor
- Viral Vectors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Immune Checkpoint Blockade121 topic
- PD-1 and PD-L1121 topic
- Cell Cycle91 topic
- Immunotherapy92 topics
- Tumor Regression92 topics
- p5391 topic
- Gene Therapy82 topics
- Signaling61 topic
- mTOR61 topic
- Bacterial Therapy51 topic
- EGFR Mutations51 topic
- NK Cell Recognition51 topic
- Natural Killer Cells51 topic
- Targeted Therapy51 topic
- Tumor Targeting51 topic
- CAR T Cells41 topic
- Chimeric Antigen Receptor41 topic
- AAV31 topic
- Viral Vectors31 topic
Where does Raymond D. Meng work?
Raymond D. Meng's main affiliation in the publication record is Sarah Cannon, United States.
How many publications and citations does Raymond D. Meng have?
OpenAlex counts 50 works and 2,162 citations for Raymond D. Meng, an h-index of 16, ranking #1,011,169 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Raymond D. Meng. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.